DeepScribe vs Nabla
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
DeepScribe
Specialty-focused ambient scribe with built-in coding, enterprise-only
Visit
|
Nabla
Ambient AI scribe that turns patient visits into clinical notes.
Visit
|
|
|---|---|---|
| RECATOOLS Score | 7.2 / 10 | 8.2 / 10 |
| Capability | ||
| Value for money | ||
| Ease of use | ||
| ASEAN readiness | ||
| API quality | ||
| Pricing | Enterprise | Freemium |
| Free tier | — | Free trial available with core documentation features and limited usage |
| Paid from | — | Free tier (up to 30 consultations/mo); Pro ~$119/month (unlimited); enterprise via contract |
| Has API | ✗ | ✓ |
| Open source | ✗ | ✗ |
| Free to use | ✗ | ✗ |
| Users | — | 85,000+ clinicians across 150+ health organisations (mid-2025) |
| Founded | — | 2018 |
| Maker | — | Nabla Technologies |
| Verdict | DeepScribe's pitch goes past note-taking into revenue cycle: automated E/M, ICD-10, and HCC coding alongside the transcript, plus a pre-visit context tool (SmartPrep) and deep specialty/oncology templates that generalist... |
Nabla has the best clinical evidence in ambient scribing: a NEJM AI randomized trial across 238 physicians and 48,000+ visits found a statistically significant 9.5% cut in documentation time. Real deployments back it up... |
| Full review → | Full review → |
← Back to AI Directory
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.